Frontlight ResearchEarly access
Trial site
CHU de Dijon-Hôpital du Bocage
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Amyloidosis1 trial
- Heart failure1 trial
- Melanoma1 trial
- Phase
- Phase 32 trials
- Status
- Active, not recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Novo Nordisk A/S1 trial
- Pierre Fabre Medicament1 trial
Running trials
Recruiting
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Amyloidosis1 recruiting
- Heart failure1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026